Cutaneous T-Cell Lymphoma
3 competing products in clinical development for Cutaneous T-Cell Lymphoma.
Pipeline by Phase
Phase 11
Phase 31
Approved1
All Products (3)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Mogamulizumab | Kyowa Kirin | Approved | Active | 47 |
| KW-0761 + Vorinostat | Kyowa Kirin | Phase 3 | Completed | 40 |
| Mogamulizumab + Brentuximab vedotin | Kyowa Kirin | Phase 1 | Recruiting | 36 |